Kiniksa Pharmaceuticals, Ltd. - (KNSA) News

Kiniksa Pharmaceuticals, Ltd. - (KNSA): $14.07

0.30 (+2.18%)

POWR Rating

Component Grades













Filter KNSA News Items

KNSA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

KNSA News Highlights

  • For KNSA, its 30 day story count is now at 4.
  • Over the past 2 days, the trend for KNSA's stories per day has been choppy and unclear. It has oscillated between 1 and 2.

Latest KNSA News From Around the Web

Below are the latest news stories about KINIKSA PHARMACEUTICALS LTD that investors may wish to consider to help them evaluate KNSA as an investment opportunity.

Kiniksa Pharmaceuticals First Quarter 2023 Earnings: Beats Expectations

Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) First Quarter 2023 Results Key Financial Results Revenue: US$48.3m (up 50% from...

Yahoo | May 3, 2023

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates

Kiniksa Pharmaceuticals, Ltd. (KNSA) delivered earnings and revenue surprises of 0% and 5.22%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 2, 2023

Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q1 2023 net product revenue of $42.7 million –– ARCALYST full-year 2023 net product revenue guidance increased to $200 - $215 million, representing ~69% year-over-year growth at the midpoint –– Final cohort of KPL-404 Phase 2 rheumatoid arthritis trial now enrolling patients; data expected in 1H 2024 – – Cash reserves now expected to fund operations into at least 2026 – – Conference call and webcast scheduled for 8:30 am ET today – HAMILTON, Bermuda, May 02, 2023 (GLOBE

Yahoo | May 2, 2023

Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023

HAMILTON, Bermuda, May 01, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, May 2, 2023, at 8:30 a.m. Eastern Time to report its first quarter 2023 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company’s website at Individuals interested in participating in the call via telephone may register here

Yahoo | May 1, 2023

Could The Market Be Wrong About Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Given Its Attractive Financial Prospects?

Kiniksa Pharmaceuticals (NASDAQ:KNSA) has had a rough three months with its share price down 26%. However, a closer...

Yahoo | April 9, 2023

7 Thrilling Biotech Stocks for Aggressive Investors to Buy

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Josh Enomoto on InvestorPlace | April 5, 2023

After Plunging -13.29% in 4 Weeks, Here's Why the Trend Might Reverse for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Kiniksa Pharmaceuticals, Ltd. (KNSA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Yahoo | March 31, 2023

7 Small-Cap Stocks to Buy for Explosive Growth Potential

Although small-cap stocks to buy presents higher risks than the large caps, the segment also enjoys critical advantages.

Josh Enomoto on InvestorPlace | March 30, 2023

12 Cheap Healthcare Stocks to Buy in 2023

In this piece, we will take a look at the twelve cheap healthcare stocks to buy in 2023. For more healthcare stocks, head on over to 5 Cheap Healthcare Stocks to Buy in 2023. The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades. Modern […]

Yahoo | March 29, 2023

HCA Healthcare (HCA) Expands in Kansas With a Medical Plaza

HCA Midwest, run by HCA Healthcare (HCA), plans to add a two-story medical plaza in Overland Park of $12 million, to be occupied by Family Health Medical Group and Town Plaza Women's Care.

Yahoo | March 27, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.713 seconds.